2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma

NCT01353755 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

195

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinoconjunctivitis
Allergic Asthma

Interventions

DRUG: Grass pollen specific immunotherapy
DRUG: Placabo

Sponsor

Allergopharma GmbH & Co. KG